Page last updated: 2024-10-25

6-hydroxychlorzoxazone and Hepatitis

6-hydroxychlorzoxazone has been researched along with Hepatitis in 1 studies

6-hydroxychlorzoxazone: chlorzoxazone metabolite in humans

Hepatitis: INFLAMMATION of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver (NAFL) have a different prognosis and should be dealt with differently."1.34Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. ( Chtioui, H; Dufour, JF; Ledermann, M; Semela, D; Zimmermann, A, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chtioui, H1
Semela, D1
Ledermann, M1
Zimmermann, A1
Dufour, JF1

Other Studies

1 other study available for 6-hydroxychlorzoxazone and Hepatitis

ArticleYear
Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:6

    Topics: Adult; Biopsy; Biotransformation; Chlorzoxazone; Cytochrome P-450 CYP2E1; Diagnosis, Differential; F

2007